World Equity Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33M Sell
5,088
-2,887
-36% -$740K 0.55% 37
2026
Q2
$2.01M Buy
7,975
+96
+1% +$20.7K 0.45% 45
2026
Q1
$1.71M Buy
7,879
+91
+1% +$20.2K 0.44% 44
2025
Q4
$1.78M Sell
7,788
-1,124
-13% -$256K 0.5% 38
2025
Q3
$2.06M Buy
8,912
+497
+6% +$101K 0.47% 44
2025
Q2
$1.56M Sell
8,415
-351
-4% -$65.2K 0.43% 50
2025
Q1
$1.82M Sell
8,766
-1,559
-15% -$303K 0.52% 43
2024
Q4
$1.84M Buy
10,325
+2,625
+34% +$483K 0.39% 51
2024
Q3
$1.52M Sell
7,700
-396
-5% -$73.9K 0.55% 42
2024
Q2
$1.39M Buy
8,096
+409
+5% +$67.8K 0.41% 69
2024
Q1
$1.4M Sell
7,687
-1,063
-12% -$183K 0.29% 91
2023
Q4
$1.36M Buy
8,750
+286
+3% +$41.7K 0.27% 90
2023
Q3
$1.27M Sell
8,464
-321
-4% -$47.1K 0.26% 97
2023
Q2
$1.18M Sell
8,785
-9,349
-52% -$1.37M 0.35% 79
2023
Q1
$1.13M Buy
18,134
+5,119
+39% +$783K 0.17% 150
2022
Q4
$2.1M Buy
13,015
+319
+3% +$48.9K 0.5% 57
2022
Q3
$1.7M Sell
12,696
-1,829
-13% -$262K 0.43% 59
2022
Q2
$2.22M Sell
14,525
-274
-2% -$41.9K 0.56% 45
2022
Q1
$2.4M Buy
+14,799
New +$2.15M 0.52% 47

Other funds holding ABBV

World Equity Group's ABBV Position: Q3 2026 in Review

World Equity Group reduced its AbbVie (ABBV) stake by 36% in Q3 2026, selling an estimated $740K and leaving 5,088 shares worth $1.33M. The position accounts for 0.55% of the portfolio, ranked #37.

World Equity Group first reported a position in ABBV in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.4M in Q1 2022. 1,120 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • World Equity Group held 5,088 shares of AbbVie worth $1.33M as of Q3 2026.
  • World Equity Group sold 2,887 AbbVie shares in Q3 2026, an estimated $740K.
  • AbbVie made up 0.55% of World Equity Group's portfolio in Q3 2026, its #37 holding.
  • World Equity Group first reported a position in AbbVie in Q1 2022 and has held it in 19 quarters since.
  • World Equity Group's AbbVie position peaked at $2.4M in Q1 2022.
  • 1,120 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on World Equity Group's 13F filing for Q3 2026, filed 14 Oct 2026.